<!doctype html><html lang=en><meta charset=utf-8><meta name=generator content="Hugo 0.78.1"><meta name=viewport content="width=device-width,initial-scale=1,viewport-fit=cover"><meta name=color-scheme content="light dark"><meta name=supported-color-schemes content="light dark"><title>Octavia 2012&nbsp;&ndash;&nbsp;Papers</title><link rel=stylesheet href=/stevengogogo/PaperNotes/css/core.min.0e6154f1fe5441faaa4f418ca1a607b9f3edbad43b1ab8782737ee279ca2c5a48c8dbe23af3340af50c91a2558bc2b55.css integrity=sha384-DmFU8f5UQfqqT0GMoaYHufPtutQ7Grh4JzfuJ5yixaSMjb4jrzNAr1DJGiVYvCtV><meta name=twitter:card content="summary"><meta name=twitter:title content="Octavia 2012"><body><section id=header><div class="header wrap"><span class="header left-side"><a class="site home" href=/stevengogogo/PaperNotes/><span class="site name">Papers</span></a></span>
<span class="header right-side"><div class="nav wrap"><nav class=nav><a class="nav item" href=/stevengogogo/PaperNotes/categories/>Categories</a><a class="nav item" href=/stevengogogo/PaperNotes/tags/>Tags</a></nav></div></span></div><div class="site slogan"><span class=title>Collection of papers I read</span></div></section><section id=content><div class=article-container><section class="article header"><h1 class="article title">Octavia 2012</h1><p class="article date">2020-10-23</p></section><article class="article markdown-body"><p><a href=https://sciwheel.com/work/#/items/3314818 target=_blank>Sciwheel</a>.</p><p><a href=https://www.jmmc-online.com/article/S0022-2828%2812%2900115-0/fulltext target=_blank>Article</a><sup id=fnref:1><a href=#fn:1 class=footnote-ref role=doc-noteref>1</a></sup></p><h2 id=molecular-mechanism>Molecular mechanism</h2><p><img src=https://els-jbs-prod-cdn.literatumonline.com/cms/attachment/040a1539-69cf-4811-a276-7d41095fcbc5/gr1_lrg.jpg alt></p><h3 id=mitochondrial-dependent-ros>Mitochondrial dependent ROS</h3><ul><li>cationic drug doxorubicin is retained in the <strong>mitochondrial inner membrane</strong> (IMM) by forming a nearly-irreversible complex with <strong>cardiolipin</strong><ul><li>Inhibiting ETC complexes</li></ul></li><li>doxorubicin treatment affects mitochondrial gene expression & suppresses cardiac mitochondrial metabolism and biogenesis</li><li>Upregulation of manganese superoxide dismutase (MnSOD): increase survival</li></ul><h3 id=nos-no-synthase-dependent-ros>NOS (NO synthase) dependent ROS</h3><ul><li>Binding of doxorubicin to endothelial NOS (eNOS) reductase domain (eNOS uncoupling) results in superoxide generation, related to doxorubicin-induced apoptosis</li><li>Inducible NOS (iNOS): controversial</li></ul><h3 id=nadph-dependent-ros>NAD(P)H-dependent ROS</h3><ul><li>doxorubicin and NAD(P)H can produce a little superoxide in the absence of any enzymatic activity</li><li>NAD(P)H oxidase as another source</li></ul><h3 id=fe--dox-complex>Fe – DOX complex</h3><ul><li>DOX decreases iron sequenster expression => more free iron => (DOX binds to iron) => toxicity</li><li>redox cycling => lipid peroxidation, protein (thiol group) oxidation</li></ul><h3 id=apoptosis>Apoptosis</h3><p><img src=https://els-jbs-prod-cdn.literatumonline.com/cms/attachment/3564db86-287a-4a46-8434-649c67129f46/gr2_lrg.jpg alt></p><ul><li>By oxidative stress</li></ul><h3 id=intracellular-calcium-dysregulation>Intracellular calcium dysregulation</h3><ul><li>Both a result and a cause of ROS-generation.</li></ul><h3 id=changes-in-the-high-energy-phosphate-pool>Changes in the high-energy phosphate pool</h3><ul><li>Depletion of ATP/ PCr, depolarizations of mitochondria due to oxidative stress</li><li>Creatine kinase (CK) is inhibited by ROS</li></ul><h3 id=endothelin-1-et-1>Endothelin-1 (ET-1)</h3><ul><li><em>survival signaling</em> in CMCs counteracted by the <em>vasoconstrictive</em> effects of endothelin-1 on the vasculature</li></ul><h3 id=extracellular-matrix-remodeling>Extracellular matrix remodeling</h3><ul><li>Inhibits MMP-1 (less tumor cell metastasis), enhances MMP-2, MMP-9 in the heart => tissue remodeling</li></ul><h2 id=symptoms-and-diagnostic-tools>Symptoms and diagnostic tools</h2><ul><li>acute, subacute and late toxicity</li><li>Acute: usually resolve spontaneously within several hours or weeks after the completion of chemotherapy in most patients</li><li>subacute: rare</li><li>Chronic: dose-dependent, monitored by trponin, LVEF&mldr;</li></ul><h2 id=therapeutic-and-preventive-possibilities>Therapeutic and preventive possibilities</h2><p><img src=https://els-jbs-prod-cdn.literatumonline.com/cms/attachment/68e0f631-5761-488a-be6a-361b05f7e88e/gr3_lrg.jpg alt></p><ul><li>most effective: modulating the <strong>dosage</strong>.</li><li>Dexrazoxane: competes Top 2β binding => prevents depletion of mitochondrial DNA</li><li>β-blocker / ACEi/ ARB: when HF is indicated</li><li>EPO?</li><li>Preventive administration of <em>sildenafil</em>, a phosphodiesterase (PDE) 5 inhibitor<ul><li>mitochondrial KATP channel opening</li><li>NOS-dependent</li><li>sildenafil and doxorubicin produce greater amounts of ROS in cancer cells. On the other hand, this combination produced less ROS in normal cells</li></ul></li><li>cardiac resynchronization therapy (CRT): implant, for non-responser to cardioprotective medication</li><li>heart transplantation</li></ul><h2 id=reference>Reference</h2><section class=footnotes role=doc-endnotes><hr><ol><li id=fn:1 role=doc-endnote><p>Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J. Mol. Cell. Cardiol. 2012;52(6):1213-1225. doi:10.1016/j.yjmcc.2012.03.006. <a href=https://www.jmmc-online.com/article/S0022-2828%2812%2900115-0/fulltext target=_blank>JMCC</a> <a href=#fnref:1 class=footnote-backref role=doc-backlink>&#8617;&#xfe0e;</a></p></li></ol></section></article><section class="article author"><p class=name>Shao-Ting Chiu</p><div class=details><a class=item href=https://github.com/stevengogogo target=_blank><span class="iconfont icon-github"></span>&nbsp;stevengogogo</a></div></section></div><div class="article bottom"><section class="article navigation"><p><a class=link href=/stevengogogo/PaperNotes/posts/ohara-2011/><span class="iconfont icon-article"></span>Ohara 2011</a></p><p><a class=link href=/stevengogogo/PaperNotes/posts/nobile-2016/><span class="iconfont icon-article"></span>Nobile 2016</a></p></section></div></section><section id=footer><div class=footer-wrap><p class=copyright>Papers</p><p class=powerby><span>Powered&nbsp;by&nbsp;</span><a href=https://gohugo.io target=_blank>Hugo</a><span>&nbsp;&&nbsp;</span><a href=https://themes.gohugo.io/hugo-notepadium/ target=_blank>Notepadium</a></p></div></section><link rel=stylesheet href=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.css integrity=sha384-zB1R0rpPzHqg7Kpt0Aljp8JPLqbXI3bhnPWROx27a9N0Ll6ZP/+DiW/UqRcLbRjq crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/katex.min.js integrity=sha384-y23I5Q6l+B6vatafAwxRu/0oK/79VlbSz7Q9aiSZUvyWYIYsd+qj+o24G5ZU2zJz crossorigin=anonymous></script><script defer src=https://cdn.jsdelivr.net/npm/katex@0.11.1/dist/contrib/auto-render.min.js integrity=sha384-kWPLUVMOks5AQFrykwIup5lo0m3iMkkHrD0uJ4H5cjeGihAutqP0yW0J6dpFiVkI crossorigin=anonymous onload=renderMathInElement(document.body);></script></body></html>